Yogic Breathing Exercise and Meditation for People With Spinal Cord Disorders
The goal of the study is to understand how well yogic breathing exercise and meditation improves breathing, fatigue, emotional well-being and quality of life in people with spinal cord disorders.
Aim 1. Evaluate the efficacy of an 8-week, virtual, coach-guided yogic breathing and meditation (YBM) program on QoL and mental health in people with spinal cord disorders.
This study will include completing several questionnaires 3 times, 8 weeks of participating in 2 sessions per week of yogic breathing exercise and meditation via Zoom and being interviewed once at the completion of the 8-week program.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
General Information You are being asked to take part in a research study. This research study is voluntary, meaning you do not have to take part in it. The procedures, risks, and benefits are fully described further in the consent form.
Purpose The purpose of the study is to understand how well yogic breathing exercise and meditation improves breathing, fatigue, and emotional well-being in people with spinal cord injury (SCI).
Duration & Visits You will complete several questionnaires (3 different times) that will take 30 minutes to complete each time, participate in 12-30-minute yogic breathing exercise and meditation sessions (over 8 weeks), complete a 25-minute interview and that you will be in the study for 2 months.
Overview of Procedures This study will include completing several questionnaires multiple times, 8 weeks of participating in 2 sessions per week of yogic breathing exercise and meditation via Zoom and being interviewed once.
Risks The most common risks include some tiredness and frustration while learning the yogic breathing exercise and meditation techniques. Loss of confidentiality is also a risk.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Hon Yuen, PhD
- Numéro de téléphone: 12059346301
- E-mail: yuen@uab.edu
Sauvegarde des contacts de l'étude
- Nom: Adrian Smith, BS
- Numéro de téléphone: 12059348931
- E-mail: adrian02@uab.edu
Lieux d'étude
-
-
Alabama
-
Birmingham, Alabama, États-Unis, 35294
- Recrutement
- University of Alabama at Birmingham
-
Chercheur principal:
- Hon Yuen, PhD
-
Contact:
- Hon Yuen, PhD
- Numéro de téléphone: 2059346301
- E-mail: yuen@uab.edu
-
Contact:
- Adrian Smith, BS
- Numéro de téléphone: 2059348931
- E-mail: adrian02@uab.edu
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- spinal cord disorders
- community-dwelling adults aged ≥ 18 years
- able to follow simple, three-step verbal instructions (e.g., close your eyes, open your mouth, close your mouth)
- access to the internet and an electronic device with videoconferencing capability
- able to set up virtual sessions with/without caregiver assistance
- sufficient English language proficiency to provide consent for study participation and complete self-report questionnaires
Exclusion Criteria:
- suicidal intent requiring emergency care
- bedridden with continuous use of noninvasive ventilation
- participating in weekly pulmonary PT, psychological therapy, or a clinical trial that could affect proposed study outcomes.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: yogic breathing and meditation
yogic breathing exercise and meditation exercise
|
yogic breathing exercise and meditation exercise
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Depressive symptoms as assessed by the PHQ-9
Délai: change from baseline in depressive symptoms at 8 and 16 weeks
|
The Patient Health Questionnaire-9 (PHQ-9) consists of nine questions inquiring about symptoms experienced over the past two weeks, ranging from low energy and sleep issues to feelings of hopelessness and self-harm.
Each question is scored from 0 to 3, with a maximum total score of 27.
Higher scores indicate more severe depressive symptomology.
|
change from baseline in depressive symptoms at 8 and 16 weeks
|
|
Patient health questionnaire (PHQ-9)
Délai: baseline, post-program (8th week), and 16th week
|
The Patient Health Questionnaire-9 (PHQ-9) consists of nine questions inquiring about symptoms experienced over the past two weeks, ranging from low energy and sleep issues to feelings of hopelessness and self-harm.
Each question is scored from 0 to 3, with a maximum total score of 27.
Higher scores indicate more severe depressive symptomology.
|
baseline, post-program (8th week), and 16th week
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Hon Yuen, PhD, University of Alabama at Birmingham
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IRB-300011535 A
- UAB (Autre identifiant: UAB)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .